Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,381.26
1,490.45
1,550.67
1,337.15
1,261.04
1,138.12
1,334.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,381.26
1,490.45
1,550.67
1,337.15
1,261.04
1,138.12
1,334.15
Raw Material Cost
725.13
797.49
879.62
764.33
694.70
661.88
732.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
263.54
253.02
245.06
212.52
180.26
194.97
187.76
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.60
2.84
7.06
13.23
19.91
25.99
10.17
Selling and Distribution Expenses
354.69
332.19
370.26
331.65
273.83
415.07
270.89
Other Expenses
-20.75
-19.65
-17.09
-15.58
-15.22
-14.15
-16.09
Total Expenditure (Excl Depreciation)
1,137.49
1,189.07
1,331.14
1,165.93
1,016.47
1,156.42
1,040.33
Operating Profit (PBDIT) excl Other Income
243.79999999999998
301.4
219.5
171.20000000000002
244.60000000000002
-18.3
293.8
Other Income
61.86
35.01
58.84
16.58
19.95
15.90
18.96
Operating Profit (PBDIT)
361.52
407.18
382.06
279.54
317.69
-25.55
390.94
Interest
1.60
2.84
7.06
13.23
19.91
25.99
10.17
Exceptional Items
1.46
2.84
-12.02
15.40
-155.43
-375.25
-17.46
Gross Profit (PBDT)
656.13
692.96
671.05
572.82
566.34
476.24
601.70
Depreciation
67.40
76.23
112.77
105.19
85.79
83.64
80.31
Profit Before Tax
293.98
330.95
250.21
176.52
56.56
-510.42
283.00
Tax
45.85
53.23
37.92
38.93
35.82
23.69
28.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
212.65
247.70
212.23
160.70
110.99
-393.62
229.67
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
212.65
247.70
212.23
160.70
110.99
-393.62
229.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
34.81
28.77
0.06
-20.74
-83.07
-130.73
30.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
247.47
276.47
212.29
139.96
27.93
-524.35
260.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,583.50
2,444.59
2,400.93
2,235.84
2,107.50
1,849.91
2,282.58
Earnings per share (EPS)
0.26
0.3
0.26
0.2
0.14
-0.48
0.28
Diluted Earnings per share
0.26
0.3
0.26
0.2
0.14
-0.48
0.28
Operating Profit Margin (Excl OI)
16.81%
19.86%
13.57%
11.8%
16.81%
-10.99%
21.86%
Gross Profit Margin
26.16%
27.32%
23.41%
21.07%
11.29%
-37.5%
27.23%
PAT Margin
15.4%
16.62%
13.69%
12.02%
8.8%
-34.58%
17.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -7.32% vs -3.89% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -10.49% vs 30.24% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -19.48% vs 15.16% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -42.86% vs -60.56% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Jinghua Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,381.26
0
1,381.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,381.26
0
1,381.26
Raw Material Cost
725.13
0
725.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
263.54
0
263.54
Power Cost
0
0
0.00
Manufacturing Expenses
1.60
0
1.60
Selling and Distribution Expenses
354.69
0
354.69
Other Expenses
-20.75
0.00
-20.75
Total Expenditure (Excl Depreciation)
1,137.49
0
1,137.49
Operating Profit (PBDIT) excl Other Income
243.78
0.00
243.78
Other Income
61.86
0
61.86
Operating Profit (PBDIT)
361.52
0
361.52
Interest
1.60
0
1.60
Exceptional Items
1.46
0
1.46
Gross Profit (PBDT)
656.13
0
656.13
Depreciation
67.40
0
67.40
Profit Before Tax
293.98
0
293.98
Tax
45.85
0
45.85
Provisions and contingencies
0
0
0.00
Profit After Tax
212.65
0
212.65
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
212.65
0
212.65
Share in Profit of Associates
0
0
0.00
Minority Interest
34.81
0
34.81
Other related items
0.00
0.00
0.00
Consolidated Net Profit
247.47
0
247.47
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,583.50
0
2,583.50
Earnings per share (EPS)
0.26
0
0.26
Diluted Earnings per share
0.26
0
0.26
Operating Profit Margin (Excl OI)
16.81%
0%
0.00
16.81%
Gross Profit Margin
26.16%
0%
0.00
26.16%
PAT Margin
15.40%
0%
0.00
15.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 138.13 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -7.32% vs -3.89% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 24.75 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -10.49% vs 30.24% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.97 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -19.48% vs 15.16% in Dec 2023
Annual - Interest
Interest 0.16 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -42.86% vs -60.56% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.81%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






